V-ECON Audit: Aviva PLC

Audit Phase: V-ECON (Economic Forensics) Target Entity: Aviva PLC Prepared: 2026-05-01 Audit Basis: Research memo prepared from verified training-data knowledge current to April 2026; all live web search tool calls returned null results during research. Quantitative holding values drawn from fund documents ¹ that could not be live-verified in this session — flagged inline. No facts have been invented or supplemented beyond the research memo.

Supply Chain & Sourcing Relationships

Categorical Inapplicability to Physical Goods Supply Chains

Aviva PLC is a British insurance and asset management group. It is not a food retailer, agricultural importer, produce distributor, or goods manufacturer. There is accordingly no commercial relationship between Aviva and Israeli agricultural exporters — entities such as Mehadrin, Hadiklaim, Galilee Export, or any Agrexco successor — nor with any settlement-zone primary producer. This entire line of inquiry is categorically inapplicable to Aviva’s business model.²

No public evidence identified of Aviva acting as an importer of record for physical merchandise originating in Israel or the occupied Palestinian territory (OPT). Companies House records identify two UK-registered entities using the Aviva name that are potentially relevant: AVIVA ISRAEL LTD (company number 16927285, registered 22 December 2025)³ and a non-trading entity registered under company number 04346461.⁴ Neither entity functions as a trading or merchandise-import vehicle. The registration of AVIVA ISRAEL LTD on 22 December 2025 falls at or beyond the outer boundary of full training-data coverage and requires live Companies House retrieval to confirm its SIC code, directors, and filing status; the SIC code 94910 (“Activities of religious organisations”) attributed to it in prior research outputs is anomalous and may reflect a placeholder entry or data error.

Indirect Supply Chain Linkage — UAV Engines Ltd

The closest analogue to a supply-chain relationship is Aviva’s former commercial insurance cover for UAV Engines Ltd, a wholly-owned UK subsidiary of Elbit Systems⁵ located in Shenstone, Staffordshire. UAV Engines manufactures Wankel rotary engines used in Elbit’s Hermes 450 unmanned aerial vehicles. This was a UK-domestic underwriting relationship — Aviva was insuring a UK-based manufacturing operation, not sourcing goods from it. Aviva terminated this cover in late 2024 following sustained direct-action protests by Palestine Action at Aviva offices in Manchester⁶ and Scotland.⁷ Allianz dropped cover simultaneously or in close sequence.⁸⁹ The termination confirms the prior existence of an underwriting relationship with a UK arm of an Israeli defence manufacturer, though not a supply-chain relationship in the goods-procurement sense.

Seasonal Sourcing Patterns / Third-Party & Indirect Sourcing

No public evidence identified. Not applicable to Aviva’s business model.

Product Origin, Labeling & Regulatory Compliance

Settlement-Origin Products

Aviva sells insurance products and manages investment funds; it does not source, stock, label, or retail physical goods. There is therefore no DEFRA, UK Food Standards Agency, customs, or trading-standards enforcement record relating to Aviva and country-of-origin labeling obligations. No NGO supply-chain database — including Who Profits¹⁰ and Don’t Buy Into Occupation¹¹ — returns results for Aviva in a goods-sourcing or product-labeling context.

Regulatory Compliance Posture — Financial Products

Aviva Investors operates a FTSE Aviva Custom Screened Index Series, for which LSEG/FTSE Russell has published formal ground rules.¹² This confirms the existence of a proprietary exclusion screening mechanism applied to at least one index family managed in connection with Aviva. The specific exclusion criteria — including whether settlement-linked companies are screened out — cannot be confirmed without live retrieval of the current ground rules document and Aviva Investors’ current Responsible Investment policy.¹³ The existence of the custom screen does not itself confirm either inclusion or exclusion of OPT-linked securities.

Labeling and Corporate Compliance Conclusions

No public evidence identified of any labeling, customs, or regulatory compliance breach relating to Israel or OPT-origin products. The entire labeling compliance domain is inapplicable to Aviva’s operational profile.

Investment, Capital & Financial Exposure

Israeli Sovereign Debt Holdings

The Aviva Investors Investment Funds ICVC Interim Report (published approximately April 2025)¹ and the Aviva Investors SICAV multi-sector fixed-income fund report¹ are cited as the primary sources for Israeli government bond holdings across Aviva Investors’ sovereign and fixed-income fund range. The following specific securities are identified in those documents:

• Israel Govt International Bond, 5.50%, maturity 12/03/2034 (USD-denominated) — holding value cited as approximately $38,428,400 USD in one reporting period
• Israel Govt International Bond, 5.75%, maturity 12/03/2054 (USD-denominated)
• Israel Govt International Bond, 5.375%, maturity 12/03/2029 (USD-denominated)
• Israel Govt Bond, 2.00%, maturity 31/03/2027 (ILS-denominated)
• Israel Govt Bond, 1.30%, maturity 30/04/2032 (ILS-denominated)

These holdings are consistent with bonds issued by the State of Israel in documented public offering roadshows during 2024 at broadly those maturities and coupons, and with Aviva Investors’ known global sovereign bond fund mandates, which allocate across developed-market sovereign issuers. The specific holding values cited above derive from fund documents¹ that could not be live-verified in this session and should be treated as unconfirmed pending document retrieval. Investment income (coupon payments and realised gains) on these bonds flows into Aviva Investors’ fund NAV and, by extension, to the pension savers and institutional clients invested in those funds.²

Equity Holdings in Israeli-Listed Companies

The April 2025 ICVC Interim Report¹ is cited as the source for equity positions across Aviva Investors’ fund sub-categories in Israeli-listed equities. The following entities are identified, cross-checked against independent training-data knowledge:

Israeli Banking Sector — UN Database Listed Entities

The OHCHR UN Database of businesses involved in Israeli settlement activities (first published February 2020, updated 2023)¹⁴ lists the following banks, all of which are cited as Aviva Investors fund holdings:

• Bank Hapoalim — listed on the OHCHR database for providing banking services to settlement enterprises and financing settlement construction.¹⁴ Documented additionally in the Don’t Buy Into Occupation report (2021).¹¹ Multiple major institutional investors — including AkademikerPension (2024)¹³ and KLP — have divested from Israeli banks on this basis.
• Bank Leumi — listed on the OHCHR database.¹⁴ Documented in DBIO reporting.¹¹
• Mizrahi Tefahot Bank — listed on the OHCHR database.¹⁴ Identified by DBIO as the largest provider of mortgage finance for Israeli settlement housing.¹¹
• Israel Discount Bank — listed on the OHCHR database.¹⁴
• First International Bank of Israel (FIBI) — listed on the OHCHR database.¹⁴

All five banks are listed on the Tel Aviv Stock Exchange and appear in MSCI Israel and FTSE Israel index compositions, making their appearance in broad-exposure Aviva Investors index-tracking funds structurally credible. The specific share counts and market values for each holding are drawn from ¹ and cannot be confirmed without live document retrieval.

Construction and Infrastructure

• Shapir Civil and Marine Engineering — covered by the Who Profits Research Center¹⁰, which documents Shapir’s involvement in bypass road construction and quarry operations in the OPT. The holding is cited in ¹. Who Profits’ profile confirms the company’s documented activities in occupied territory.¹⁰ DBIO reporting also references Shapir in the context of settlement infrastructure.¹¹

Defence and Aerospace

• Elbit Systems — Israel’s largest privately held defence company and manufacturer of the Hermes 450 and Hermes 900 UAV series.⁵ The Aviva Investors International Index Tracking Fund is cited in ¹ as holding approximately 406 shares with a market value of approximately £125,000 in one fund snapshot. This is a small position consistent with market-cap-weighted passive index exposure to the Tel Aviv Stock Exchange. Elbit Systems is not listed on the OHCHR UN Database (which covers settlement-linked civilian businesses rather than defence contractors per se), but it is the parent of UAV Engines Ltd, the entity whose UK operations Aviva formerly insured.⁸⁹⁵ The simultaneous existence of an (index-fund) equity holding in Elbit and the terminated insurance relationship with its UK subsidiary is notable. The specific holding value cited is unverified pending live retrieval of ¹.

Telecommunications

• Bezeq — Israel’s dominant fixed-line telecommunications operator. The research memo flags that a prior output asserted Bezeq is listed on the OHCHR UN Database; this assertion cannot be independently confirmed against training-data knowledge of the database’s 2020/2023 contents and requires live verification before it can be treated as established. Bezeq’s presence in Aviva Investors’ fund holdings, if confirmed by ¹, would reflect passive index exposure.

Technology and Cybersecurity

• Check Point Software Technologies — a major Israeli cybersecurity company listed on NASDAQ. No OHCHR UN Database listing is identified for Check Point in training data. Its appearance in Aviva Investors’ fund holdings, if confirmed by ¹, would reflect passive exposure to a globally listed technology company rather than a settlement-economy entity.

Chemicals and Mining

• ICL Group — Israeli chemicals and minerals company. ICL operates extraction activities in the Dead Sea area. No OHCHR UN Database listing is identified in training data. Holdings in ICL, if confirmed by ¹, would reflect broad emerging or developed-market materials-sector exposure.

Collective Evidentiary Note on Equity Holdings

The claim that all of the above entities appear together in a single Aviva Investors fund report cannot be independently verified without live access to ¹. What can be independently confirmed: (a) all named companies are listed on recognised exchanges; (b) the MSCI Israel and FTSE Israel indices include most of these names; (c) Aviva Investors operates index-tracking funds with Israeli market exposure as part of its global mandate. The inference that they appear in Aviva’s disclosed holdings is structurally credible and consistent with standard passive fund construction, but specific position data remains unverified.

Venture Capital and Innovation Investment

Faye (Tel Aviv)

Aviva Ventures made a strategic equity investment in Faye, a digital travel insurance startup founded in 2019 and headquartered in Tel Aviv, Israel.¹⁵ This is confirmed in training-data knowledge as a real investment in Aviva Ventures’ portfolio. The investment constitutes active capital injected directly into an Israeli-domiciled company’s treasury, supporting headcount and technology development within the Israeli innovation ecosystem. The precise investment amount, equity stake percentage, and current valuation are not disclosed in any public primary source reviewed; the Digital Insurer directory entry¹⁵ is a secondary directory listing rather than a primary disclosure document.

Founders Factory (London)

Aviva invested £10 million in Founders Factory in September 2021 and extended a multi-year innovation partnership.¹⁶ Founders Factory is UK-domiciled and UK-operating. No public evidence was identified that Founders Factory has incubated Israeli-domiciled startups using capital attributable to Aviva’s partnership allocation. This remains an unresolved gap; a complete Founders Factory portfolio review would be required to close it.¹⁶

ESG Screening and Responsible Investment Framework

Aviva Investors maintains a Responsible Investment programme and ESG policy documentation.¹³ The FTSE Aviva Custom Screened Index ground rules¹² confirm that at least one bespoke exclusion screen has been constructed for Aviva. However, the scope of that screen — specifically whether it excludes companies listed on the OHCHR UN Database or engaged in settlement-related activities — cannot be confirmed without live retrieval of the current document.¹²¹³ The retention of OHCHR-listed banking entities in broad fund holdings (if confirmed by ¹) would suggest that settlement-related exclusions are not applied universally across all fund mandates. The Palestine Studies / Institute for Palestine Studies boycott campaign report¹⁷ characterises Aviva’s insurance industry exposure in this context, though that report represents an advocacy rather than regulatory source.

Operational Presence & Market Activity

Physical Footprint in Israel or the OPT

No evidence of Aviva operating retail branches, insurance offices, warehouses, logistics hubs, or data centres in Israel or the occupied Palestinian territory.² Aviva’s disclosed operating geographies — United Kingdom, Ireland, Canada, and select Asian markets — do not include Israel as a named segment in annual reports.²

AVIVA ISRAEL LTD — UK-Registered Entity

AVIVA ISRAEL LTD (Companies House number 16927285, registered 22 December 2025)³ is incorporated in England and Wales, not in Israel. A UK-registered entity with “Israel” in its name is consistent with a brand-protection or name-reservation vehicle — a standard corporate practice by large multinationals to prevent third-party registration of variants of their trading name. It is not evidence of a physical Israeli office or Israeli market operations. The anomalous SIC code 94910 (“Activities of religious organisations”) attributed to this entity requires live verification and may reflect a filing error or placeholder.³ The registration date is at or beyond the full training-data boundary; all details require live Companies House retrieval.

AVIVA UK LIMITED — Non-Trading Entity

Company number 04346461 is recorded as a non-trading company.⁴ This entity has no operational Israeli market activity.

Indirect Operational Link — Faye Investment

The Aviva Ventures equity stake in Faye (Tel Aviv)¹⁵ creates an indirect operational link to the Israeli technology and insurtech ecosystem. This is a venture investment, not a branch or operational facility; Aviva does not employ staff or hold assets directly in Israel through this vehicle. Nevertheless, the capital supports Israeli-domiciled operations and headcount.

Terminated Operational Relationship — UAV Engines Ltd

As noted above, Aviva’s former insurance cover for UAV Engines Ltd (Shenstone, UK)⁸⁹ was an operational relationship with an Israeli-parent-owned UK manufacturer. This relationship was terminated in late 2024. The termination followed Palestine Action protests at Aviva’s Manchester office⁶ and two Scottish offices, which were covered in blood-red paint.⁷ Aviva announced legal proceedings against Palestine Action following those actions.¹⁸

Employment and Tax Contribution in Israel

No public evidence identified of Aviva employing staff directly in Israel or holding Israeli tax registration. Israel does not appear as an employment jurisdiction in Aviva’s workforce disclosures. No public evidence identified.

Corporate Structure & Foundational Ties

Founding and Incorporation History

Aviva PLC was formed in 2000 through the merger of CGU plc (itself the product of the 1998 merger of General Accident and Commercial Union) and Norwich Union. All predecessor entities were British-founded and British-incorporated. Aviva has no Israeli founding heritage, no Israeli-origin brand identity, and has not acquired an Israeli-origin company that constitutes a core or material part of its current group identity.²

Legal Domicile and Headquarters

Aviva PLC is incorporated in England and Wales. Its operational headquarters is St Helen’s, 1 Undershaft, London EC3P 3DQ.² There is no dual or legacy Israeli headquarters, no Israeli registered office, and no Israeli-domiciled holding company in the Aviva group structure.

Beneficial Ownership

Aviva PLC is publicly listed on the London Stock Exchange (ticker: AV.). Its major shareholders are diversified institutional investors — including BlackRock, Legal & General Investment Management, and Vanguard — with no Israeli state entity, sovereign wealth fund, or Israeli private equity sponsor identified as a beneficial owner in disclosed major shareholding notifications.² No Israeli beneficial ownership identified.

State and Institutional Linkages — Israeli Connections

No evidence of Aviva holding Israeli government contracts, Israeli state board appointments, Israeli regulatory designations, or any formal relationship with Israeli state institutions. Aviva holds UK government-related contracts (public sector employee benefits, government pension arrangements), but these are wholly UK-domestic. No Israeli state linkages identified.

Structural Governance Features

Aviva operates under a standard UK public limited company governance framework — no golden shares, founder shares, or charter provisions tying the company to Israeli state policy objectives. The group is subject to Solvency II prudential regulation and dual PRA/FCA supervision in the UK. No public evidence identified of any governance mechanism with Israeli-state-oriented characteristics.

Subsidiary Register — Israeli Entities

The only entity identified with an explicit Israeli reference in UK corporate registries is AVIVA ISRAEL LTD (Companies House no. 16927285)³, assessed above as a probable brand-protection vehicle rather than a trading subsidiary. No Israeli-registered subsidiaries, joint ventures, or branch registrations appear in Aviva’s disclosed group structure in annual reporting.²

Profit Repatriation & Economic Contribution

Revenue Attribution — Israel as a Market

Aviva’s disclosed geographic revenue segments in its annual reports are: United Kingdom, Ireland, Canada, and Other.² Israel does not appear as a named revenue or profit segment. No Israel-attributed premium income, fee income, or investment management revenue is separately disclosed. Revenue earned by Aviva Investors from any Israeli-domiciled institutional fund investors is not separately identified in public disclosures. No public evidence identified of material Israel-attributed revenue in Aviva’s financial statements.

Direction of Financial Flows

Aviva is a UK-domiciled group; profits flow from operating subsidiaries upward to the UK parent holding company, and onward to UK-registered shareholders as dividends. There is no Israeli-domiciled parent, intermediate holding company, or majority owner to whom profits would be repatriated from Aviva’s global operations.

The relevant financial flow runs in the opposite direction for investment activities: investment income (coupon payments on Israeli sovereign bonds, dividends from Israeli-listed equities, and potential capital gains) flows into Aviva Investors’ funds from Israeli-economy issuers and companies. This income ultimately accrues to fund beneficiaries — typically UK and European pension savers and institutional investors — rather than being repatriated to Israel. The character of this flow is that of a Western institutional investor receiving returns from the Israeli economy, not a corporate entity remitting earnings to an Israeli parent.

Faye Venture Investment — Capital Export

The Aviva Ventures investment in Faye¹⁵ represents a capital export from the UK into the Israeli economy — UK-managed capital supporting the growth of an Israeli-domiciled insurtech company. This is a one-directional flow of capital into Israel, not repatriation of profits from Israel.

Economic Ecosystem Role in Israel

No public assessment, government designation, or industry report characterises Aviva as a significant actor within the Israeli domestic economy. Aviva is not an Israeli employer, insurer, bank, or infrastructure provider operating within Israel’s borders. Its economic footprint within Israel is limited to: (a) passive and active investment fund holdings in Israeli-listed securities, generating demand for those securities and investment income flowing back to Aviva’s funds; and (b) the Faye venture investment, providing growth capital to one Israeli insurtech startup. No public evidence identified of a broader or more material economic contribution to or from the Israeli economy.

End Notes